Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $64.02 in the prior trading day, Belite Bio Inc ADR (NASDAQ: BLTE) closed at $67.44, up 5.34%. In other words, the price has increased by $5.34 from its previous closing price. On the day, 86180.0 shares were traded. BLTE stock price reached its highest trading level at $70.0 during the session, while it also had its lowest trading level at $62.5305.
Ratios:
Our goal is to gain a better understanding of BLTE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 24.76 and its Current Ratio is at 24.76. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on December 14, 2023, initiated with a Buy rating and assigned the stock a target price of $60.
On July 28, 2023, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $43.
On July 26, 2023, SVB Securities started tracking the stock assigning a Outperform rating and target price of $25.SVB Securities initiated its Outperform rating on July 26, 2023, with a $25 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 20 ’24 when Wei-Cheng Liaw bought 5,999 shares for $82.53 per share.
Nathan Mata bought 30,000 shares of BLTE for $2,470,200 on Nov 19 ’24. On Oct 03 ’24, another insider, Yu-Hsin Lin, who serves as the CEO, Chairman of the company, bought 40,000 shares for $48.00 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BLTE now has a Market Capitalization of 2082500096.
Stock Price History:
Over the past 52 weeks, BLTE has reached a high of $86.53, while it has fallen to a 52-week low of $31.00. The 50-Day Moving Average of the stock is 5.75%, while the 200-Day Moving Average is calculated to be 34.70%.
Shares Statistics:
The stock has traded on average 64.22K shares per day over the past 3-months and 93910 shares per day over the last 10 days, according to various share statistics. Shares short for BLTE as of 1731628800 were 241075 with a Short Ratio of 3.75, compared to 1728950400 on 270587. Therefore, it implies a Short% of Shares Outstanding of 241075 and a Short% of Float of 1.8599999999999999.
